Matinas BioPharma Holdings, Inc. announced the appointment of Jerome D. Jabbour, Co-founder and President of Matinas, as its Chief Executive Officer (CEO) and a member of its Board of Directors, effective immediately. As part of a planned transition, Roelof Rongen has stepped down as CEO and a member of the Board. Mr. Jabbour is a Co-founder of Matinas and has served as President since March 2016 and as Executive Vice President, Chief Business Officer since 2013.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1726 USD | -1.76% | -2.76% | -20.17% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.17% | 44.07M | |
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- MTNB Stock
- News Matinas BioPharma Holdings, Inc.
- Matinas BioPharma Announces Executive Changes